Search research articles
Contact Us
Filters
Showing results (71-80 of 130) with videos related to
Page
of 13
Sort By:
Leukemia
|
May 6, 2014
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
Ellen Weisberg, Atsushi Nonami, Zhao Chen, et al.
The Journal of Biological Chemistry
|
July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism
Margret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2014
Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R
Ellen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Nature Structural & Molecular Biology
|
September 10, 2013
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Angela V Toms, Anagha Deshpande, Randall McNally, et al.
Plos One
|
February 26, 2013
Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells
Ellen Weisberg, Qingsong Liu, Xin Zhang, et al.
The Journal of Biological Chemistry
|
December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells
Klaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Journal of Cellular and Molecular Medicine
|
January 23, 2020
Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia
Ellen Weisberg, Chengcheng Meng, Abigail E Case, et al.
International Journal of Oncology
|
April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines
Tamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Breast Cancer Research : BCR
|
April 2, 2024
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, et al.
Breast Cancer Research : BCR
|
February 28, 2016
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 130) with videos related to
Sort By:
Page
of 13
Leukemia
|
May 6, 2014
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
Ellen Weisberg, Atsushi Nonami, Zhao Chen, et al.
The Journal of Biological Chemistry
|
July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism
Margret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2014
Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R
Ellen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Nature Structural & Molecular Biology
|
September 10, 2013
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Angela V Toms, Anagha Deshpande, Randall McNally, et al.
Plos One
|
February 26, 2013
Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells
Ellen Weisberg, Qingsong Liu, Xin Zhang, et al.
The Journal of Biological Chemistry
|
December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells
Klaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Journal of Cellular and Molecular Medicine
|
January 23, 2020
Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia
Ellen Weisberg, Chengcheng Meng, Abigail E Case, et al.
International Journal of Oncology
|
April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines
Tamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Breast Cancer Research : BCR
|
April 2, 2024
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, et al.
Breast Cancer Research : BCR
|
February 28, 2016
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, et al.
Page
of 13